Vice-President J.D. Vance has thrown his political weight behind the Make America Healthy Again (Maha) movement at a summit in Washington DC, as the sprawling initiative faces scrutiny over its shifting alliance between grassroots activists and corporate interests.
The gathering on 29 September brought together Vance, Health Secretary Robert F Kennedy Jr, and representatives from major corporations including UnitedHealth, Walmart and Anthropic. Speaking alongside Kennedy, Vance promoted his anti-fraud efforts targeting Medicaid, Medicare and the Affordable Care Act marketplace, claiming discovery of nearly $250 billion in fraud since taking charge of an anti-fraud task force.
The appearance signals Vance’s positioning as the inheritor of the Make America Great Again brand while courting Maha’s base of supporters. This comes as the Trump administration’s popularity declines amid the ongoing conflict in Iran and rising inflation, with more Americans viewing both the president and vice-president unfavourably than favourably according to recent polling.
Maha’s Corporate Pivot Sparks Grassroots Backlash
The second annual Maha summit revealed growing tensions within the movement, which originally emerged from anti-vaccine activism and nutrition-focused advocacy. While the inaugural event featured speakers from environmental and health-conscious communities, this year’s programme prioritised corporate sponsors at the expense of grassroots voices.
Companies paying $300,000 secured speaking opportunities and private meetings with Kennedy and CMS administrator Mehmet Oz, according to Bloomberg reporting. Grail, a cancer treatment developer whose experimental therapy awaits FDA approval, served as a top sponsor. Critics argue this structure creates a “pay-to-play” environment that undermines the movement’s original mission.
Maha-affiliated organisation Maha Holdings charges members £6,000 annually, with Kennedy’s 29-year-old son Finn serving as its sole board member. The organisation’s director, Tony Lyons, has compensated Kennedy £4 million over the past year. Professor Art Caplan of NYU’s Grossman School of Medicine called the summit “a giant conflict of interest” and described the arrangement as “ethically disturbing”.
Former Maha activists expressed frustration at being excluded from the conversation. Dr Mary Talley Bowden, who previously faced disciplinary action for providing unproven COVID treatments, questioned why grassroots voices were absent. Kelly Ryerson, known as the “Glyphosate Girl”, noted the speaker lineup “could not be less Maha” than what characterised the movement’s origins.
Vance Courts Anti-Establishment Base with Controversial Claims
During his remarks, Vance targeted undocumented immigrants as the primary source of fraud in federal health programmes, claiming states “don’t enforce” eligibility requirements. He stated that “close to $250bn in fraud just since I’ve been leading the anti-fraud task force” has been identified, though he provided no documentation to substantiate claims that Medicare benefits are being improperly accessed by undocumented individuals.
Speaking with Kennedy, Vance criticised the efficiency of European health systems while simultaneously advocating for stronger fraud detection within American programmes. The vice-president’s approach appears to align with broader Trump administration efforts to reduce regulatory oversight rather than increase it.
Vance also engaged with the audience through social media savvy, trading memes about the “carnivore diet” and joking about his political rivals. He described coordinated efforts with Kennedy and other cabinet members to “beat social media to the memes”, referencing a recent image of Senator Marco Rubio in a blonde wig.
Polling suggests Vance’s strategy may face challenges. While Kennedy’s faction has been crucial to Trump’s 2024 victory, only 23% of Americans view the health secretary favourably according to an Annenberg Public Policy Center survey. Additionally, 68% of rural Maha supporters reported that Trump’s health policies have had “a negative effect or no impact” on their communities, indicating a disconnect between the administration’s initiatives and their intended beneficiaries.
AI and Medical Authority Take Center Stage
Kennedy positioned artificial intelligence as a solution to what he termed “medical tyranny”, arguing that AI systems can provide more accurate information than traditional experts. He cited examples where public health guidance contradicted what AI might suggest, including mask mandates and vaccine efficacy claims.
“We’re never, ever again going to be able to be dominated by public officials who tell us ‘trust the experts’,” Kennedy declared, emphasizing AI’s potential to challenge established medical authority.
The health secretary praised OpenAI, noting the company holds millions in US government contracts. He quoted the company’s Sam Altman: “It would be malpractice for a doctor to make a diagnosis or prescription without checking AI first.”
According to Pew Research, 32% of Americans consult AI for medical information, though studies indicate these systems are inaccurate approximately 25% of the time. Kennedy framed this technological shift as liberation from expert-driven decision making, suggesting AI could correct what he views as erroneous public health recommendations.
Caplan observed that Kennedy’s “fringy science agenda was on full display” and warned that if Kennedy maintains his alliance with Vance and that duo wins election, “it gives him power to pursue some things that he cares about.”
Why it Matters
The convergence of political ambition, corporate influence and health policy represents a significant shift in American governance that could reshape healthcare delivery for decades to come. Vance’s embrace of Maha while courting corporate backers signals a move away from grassroots activism toward establishment politics, potentially undermining the very constituencies that propelled the movement to prominence. The summit’s emphasis on profit over principle raises fundamental questions about transparency and accountability in public health policy, particularly as AI technology becomes increasingly central to medical decision-making. This fusion of political power, corporate money and health advocacy creates a dangerous precedent where access to influence can be purchased, threatening democratic principles while reshaping the landscape of American healthcare.
